IBSA USA
Nicholas Hart serves as Chief Executive Officer at IBSA Pharma Inc. and holds a board member position at Yaral Pharma, both since November 2022. Previously, Nicholas led Ascend Therapeutics as President and CEO from January 2020 to December 2022 and held the title of President, Specialty at Lupin Pharmaceuticals from May 2018 to January 2020. At Ferring Pharmaceuticals, Nicholas was Business Unit Head, overseeing the Reproductive Endocrinology business from September 2013 to May 2018. Nicholas's career also includes senior roles at URL Pharma as Senior Vice President of Marketing and Sales, and at Emisphere Technologies as Vice President of Strategy and Development. Earlier experience includes serving as Therapeutic Area Leader for Women's Healthcare at Organon Pharmaceuticals. Nicholas Hart earned an MBA in Finance and International Business from NYU Stern School of Business and attended the United States Military Academy at West Point.
This person is not in any teams
This person is not in any offices
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.